Moderna (MRNA) is working on an early-stage Hantavirus vaccine

Moderna's announcement about developing an early-stage Hantavirus vaccine reflects its ongoing innovation and diversification in the biotech space.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

AWS (AMZN) reports complete recovery of increased error rates and query failures for Redshift clusters in the US East 1 region

A suspected oil spill spanning tens of square kilometres appears in satelite imagery of west of Iran’s Kharg Island, via Al Jazeera

Moderna (MRNA) is working on an early-stage Hantavirus vaccine

Michael Burry purchased MercadoLibre (MELI) this morning

ECB's Nagel says they will do whatever is needed to contain energy price jumps

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

While this may not immediately impact its stock price, it signals the company's commitment to broadening its vaccine portfolio, which could attract attention from investors looking for growth opportunities and long-term potential in bio-pharmaceuticals.

Related headlines

The whole workspace, free to try.

Try it free